JUNO THERAPEUTICS INC's ticker is JUNO and the CUSIP is 48205A109. A total of 214 filers reported holding JUNO THERAPEUTICS INC in Q3 2017. The put-call ratio across all filers is 0.99 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $85,211,000 | +1.9% | 1,864,174 | 0.0% | 94.86% | -0.1% |
| Q3 2017 | $83,627,000 | +50.1% | 1,864,174 | 0.0% | 94.97% | +4.1% |
| Q2 2017 | $55,720,000 | +15.8% | 1,864,174 | -14.0% | 91.26% | +4.6% |
| Q1 2017 | $48,121,000 | +17.7% | 2,168,601 | 0.0% | 87.21% | +3.1% |
| Q4 2016 | $40,878,000 | -37.2% | 2,168,601 | 0.0% | 84.62% | -1.7% |
| Q3 2016 | $65,080,000 | -5.0% | 2,168,601 | -1.7% | 86.12% | -2.0% |
| Q2 2016 | $68,516,000 | +12.2% | 2,205,926 | +37.6% | 87.91% | +4.8% |
| Q1 2016 | $61,042,000 | -13.4% | 1,602,562 | 0.0% | 83.87% | -2.2% |
| Q4 2015 | $70,465,000 | – | 1,602,562 | – | 85.76% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| IFP Advisors, Inc | 3,484 | $159,000 | 0.01% |
| Omega Fund Management, LLC | 0 | $0 | 0.00% |
| GLENMEDE TRUST CO NA | 156 | $7,000 | 0.00% |